Literature DB >> 31249040

Plan to use second Ebola vaccine sparks debate.

Kai Kupferschmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31249040     DOI： 10.1126/science.364.6447.1221

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

1.  Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections.

Authors:  Irina N Gaisina; Norton P Peet; Letitia Wong; Adam M Schafer; Han Cheng; Manu Anantpadma; Robert A Davey; Gregory R J Thatcher; Lijun Rong
Journal:  J Med Chem       Date:  2020-06-17       Impact factor: 7.446

2.  Potential test-negative design study bias in outbreak settings: application to Ebola vaccination in Democratic Republic of Congo.

Authors:  Carl A B Pearson; W John Edmunds; Thomas J Hladish; Rosalind M Eggo
Journal:  Int J Epidemiol       Date:  2022-02-18       Impact factor: 7.196

3.  Immunization strategies in networks with missing data.

Authors:  Samuel F Rosenblatt; Jeffrey A Smith; G Robin Gauthier; Laurent Hébert-Dufresne
Journal:  PLoS Comput Biol       Date:  2020-07-09       Impact factor: 4.475

4.  Ethical considerations for epidemic vaccine trials.

Authors:  Joshua Teperowski Monrad
Journal:  J Med Ethics       Date:  2020-05-15       Impact factor: 2.903
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.